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POLYTHIAZIDE IN THE TREATMENT OF 
CONGESTIVE HEART FAILURE 
JOHN W . KEYES, M.D., GERALD M . BRENEMAN, M.D., JOSE R. DE JESUS, JR., M.D."' 
T H E INTRODUCTION of chlorothiazide and its analogues in the past few years have 
made available potent oral diuretics which approach the organic mercurial compounds 
in efficacy. These drugs have shifted the emphasis from parenteral mercury, particularly 
for the long term management of various derivatives, all appear to be effective and 
safe diuretics. 
Al l of these compounds are active saluretic agents inhibiting tubular reabsorption 
of sodium, and causing increased excretion of chlorides. Potassium excretion is also 
significantly increased, but varies somewhat, depending on the particular analogue in 
use. Potency of these various analogues in the production of salt and water excretion 
together with a more prolonged action on single dose administration and a lessened 
tendency to kaliuresis is most desirable. 
The present report deals with the evaluation of polythiazide** (P2525), (Fig. 1), 
the most recent thiazide compound to be used by us in the treatment of cardiac edema. 
H^NSO^ 
H2SCH2CF3 
N,-CH, 
TOLYTHIAZIDE 
2 - i n e t h y l - 3 - ( 2 , 2 , 2 - t r i f l u o r o e t h y l t h i o m e t h y l ) - 6 - c h l o r o - 7 - s u l f a m y l 
3-4 d i h y d r o - l , 2 , 4 - b e n z o t h i a d i a E i n e 1 ,1 d i o x i d e 
* Division of Cardiovascular Disease. 
"""Supplied as Renese, Pfizer Laboratories. New York, New York. 
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M E T H O D OF S T U D Y 
Fourteen cases of congestive heart failure were utilized in the evaluation, one of these 
was studied in the out-patient department and 13 cases were hospitalized patients. One of 
the cases was studied twice (2 different admissions). A l l cases were digitalized concomitantiy 
but did not receive mercurials or other diuretics except the routine use of ammonium chloride 
or potassium chloride for acidifying purposes or as replacement therapy. Mercurials were 
used in several instances either before or after courses of polythiazide therapy for comparison 
purposes. 
Serum electrolyte determinations (Na, K, Cl, HCO3) were made during the control period 
and periodically in the course of polythiazide administration. 
Nine patients had arteriosclerotic heart disease, 4 had chronic rheumatic heart disease, 
and I hypertensive heart idsease. A l l patient's exhibited edema, and were placed on bed 
rest and a 400 mgm. sodium diet. Daily weight and fluid intake and output were recorded. II 
Polythiazide was administered in a dose of 4 to 16 mgm. daily in single or divided doses 
the course of treatment ranged from 2 days to 10 days continuous daily administration the 
average being 5 to 7 days. 
One out-patient received the drug over a 14 day period but only every other day for 
the last 7 days. Results: The diuretic response in 14 patients with 15 separate periods of 
treatraent is suramarized in Table I . 
In 5 patients, twenty-four hour total urine volume collections were obtained prior to 
and during administration of polythiazide to evaluate the effect on excretion of sodium 
potassium, chloride, and bicarbonate. 
Case Discussion: 
The cases ranged f r o m mi ld heart failure to those resistant to diuretics. I n the 
latter instances resistance was exclusive of electrolyte depletion as a related cause. 
There were two cases classified as mild congestive failure (Cases 7 and 12). 
Case 7 received 8 mgms. daily in two divided doses (4 mgms. each) over a 4 
day period. There was mild pulmonary congestion and minimal congestive hepa-
tomegaly. Since the patient was an acute myocardial infarction he could not be 
weighed. The clinical response was good as evidenced by rapid improvement and 
by an increase in urine 24 hour volume over the four day period of drug ad-
ministration. Electrolyte excretion studies showed a twofold increase in sodium and 
chloride and a four fo ld increase in potassium. A mild fa l l in serum potassium and 
a rather marked drop in serum chlorides occurred. 
Case 12 had only a fai r response, but received only 4 mgms. of drug as a 
single daily dose. Despite only a small weight loss, excretion studies indicated a 
four to five fo ld increase in sodium and chloride excretion. I t is possible a 6 to 
8 mgm. dose would have produced a greater edema weight loss. I n this particular 
case, however, a mercurial was given (meralluride, 2 ml . ) and no better response 
occurred. 
There were nine cases of moderately severe congestive heart failure manifested 
by considerable hepatic congestion and ankle edema. They were not all in an early 
stage of this condition, some cases having been under previous therapy fo r con-
siderable periods, but all were still responsive to diuretics — none were in a resistant 
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TABLE I 
CASE DIAGNOSIS 
INITIAL 
WEIGHT 
(LBS.) 
FINAL 
WEIGHT 
(LBS.) 
TOTAL 
WEIGHT 
LOSS 
(LBS.) 
Nin-lBEH 
OF 
DAYS KEMjlRKS 
1 ASHD 143 1165/4 27'/* « Excellent response; mild hypochloremic a l k a l o s i s ; 
no hypokalemia 
2 ASHD 201)2 I50!i 9 E.xcellent response; mila hypochloremic a l k a l o s i s ; 
no hypokalemia 
3 A3HU 2035i 180 2>% 7 Excellent response; moderate hypokalemia and 
hypochloremic a l k a l o s i s 
if ASHD 17?:.: 152>i! 21 6 Excellent response; moderate hypochloremic alkalosis 
5 90)4 5 i Good response; mild hypochloremic a l k a l o s i s ; 
hypokalemia produced 
6 RHD 109)4 7 5 Good response; mild hypochloremic a l k a l o s i s ; 
mercaptoraerin did no better 
7 ASHD Acute 
I n f a r c t i o n 
4 Not weighed; good response; mild hypochloremic 
alkalosis 
8 RHD 144 140 4 5 Poor response; resi s t a n t to mercurial d i u r e t i c s 
9 ASHD 144 138 6 10 Fair response; r e s i s t a n t congestive f a i l u r e ; 
moderately severe hypoohloremia 
10 131 128>2 2)4 2 Poor response 
11 RHD 106)4 105K i}^ 3 Poor response alone; good response i n combination 
with mercury 
12 ASHD 157)4 3K 3 Fair response; response to mercury no better 
13 117 116 1 2 Poor response 
14 HHD 300 277 23 14 Excellent response; OPD case 
15 - 2nd 
admission 
of Case #1 
ASHD 134;i 126;. b 4 Excellent response; no hypoohloremia 
5 
N 
S3 
ASHD - a r t e r i o s c l e r o t i c heart disease 
HHD - hypertensive heart disease 
RHD rheumatic heart disease 
KEYES, BRENEMAN AND de JESUS 
stage. One of these cases had two separate hospital admissions and received two 
periods of therapy, (Case 1). There were six instances of excellent response in five 
cases treated. Two cases were classified as a good response and two cases responded 
poorly. One of the latter cases had been resistant to other diuretics and received 16 
mgms. daily in two divided doses (Case 10). The other poor response occurred on 
a 4 mgm. single daily dose. In four of the six excellent responses, 6 or 8 mgms. 
was given in 24 hours as single or divided doses. The other two excellent responses 
occurred on only 4 mgms. as a single daily dose. The response to less than 6 mgms. 
in 24 hours gave poorer results in one case where the higher dose worked well. In 
this total group single daily doses seemed as effective as divided doses. In one case 
that showed an excellent response on 4 mgms. single daily dose — continued daily 
weight loss of edema fluid occurred when the drug was given as 4 mgm. every 
other day suggesting long continued activity. The daily loss was somewhat less on 
the in between days when the patient did not receive the drug (Case 14). 
There were 3 cases classified as resistant to therapy. One (Case 9), responded 
in a fair manner losing six pounds in a 10 day period. This may well indicate a 
good result since this case had not responded as well to parenteral mercurials even 
after correction of hypochloremia. A single 8 mgm. daily dose was used. The second 
case responded poorly losing only four pounds during a five day course of therapy. 
A third (Case 11), was resistant to mercurials, and treatment with polythiazide alone 
gave no better response, but slightly more diuresis occurred when both drugs were 
given in combination. 
Electrolyte excretion studies: 
Daily twenty-four hour quantitative urine collections were made in five cases. 
There was a marked increase (2 to 5 fold) of sodium and chloride and an increase 
in potassium varying considerably from 1.5 times to 4 times the control excretion. 
However, in four of the five cases it was no greater than two times the control 
period. Two of the fourteen patients developed mild hypokalemia without clinical 
symptoms. Hypochloremic alkalosis occurred in most cases of a mild degree, but in 
one case (Case 9) was severe. 
The following case illustrates an excellent result. 
A. K., was a 68 year old man with arteriosclerotic heart disease and advanced 
congestive heart failure. On admission there was cardiomegaly with a protodiastolic 
gallop and distended neck veins. He had soft pitting edema extending to the thighs 
and sacrum as well as ascites, hepatomegaly, and pleural and interlobar fluid. 
He lost no weight during a two day period during which he was digitalized. 
Polythiazide was administered in a dose of 8 mgms. daily for 3 days and then reduced 
to 4 mgms. daily for another 4 days. He lost a total of 26'/4 pounds during this 
time after which he was felt to have achieved a "dry weight." Table I I summarizes 
the results of the 24 hour urine excretion studies as well as the serum electrolyte 
response. No potassium or chloride supplements were administered during this time. 
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I 
A.K. (Case #1) 
No. 902431 
URINE SERUM (MEQ/L) 
Day 
Dosage 
(mg.) 
Weight 
( l b s . ) 
Volume 
24 h r s . 
Sodium 
Meq/Vol 
Potassium 
Meq/Vol 
Chloride 
Meq/Vol 
Bicarb. 
Meq/Vol Sodium Potassium Chloride 
Carbon 
Dioxide 
Control 0 143 750 110 55 115 0 137 5.0 105 25.2 
1 8 138 2100 222 45 192 0 
2 8 13314 3100 328 49 89 4 133 3.4 106 28.6 
3 6 127 3900 401 78 292 0 
4 4 124 3720 272 78 232 0 132 4.3 99 28.6 
5 4 121 3020 243 75 213 0 
6 4 119^ 4 1130 89 30 73 14 130 4.2 100 25,2 
7 4 116% 1860 145 48 83 32 133 4.6 96 31.6 
Table I I 
•— 
> 
=; 
S3 
S3 
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290 
275 
Case F.L. #67 97 54 
Hypertensive Heart Disease 
Congestive Heart Failure Group I I 
P o l y t h i a z i d e 4 mfim. d a i l y 
I I I I I I I 
P o l y t h i a z i d e 
4 mgm. q . o . d . 
-1 
7 8 9 10 
Table I I I 
11 12 13 14 
Table I I I illustrates an out-patient (Case #14) with an excellent response showing 
the effectiveness of a single daily dose and a continued daily edema weight loss 
when the drug was reduced to 4 mgms. every other day. It is believed that continued 
diuretic activity lasts beyond the twenty-four hour period though of a lessened degree 
as compared to daily administration. 
Toxicity: 
One patient developed a maculopapular rash that cleared promptly on omission 
of the drug without any serious sequelae. No serious intolerance was noted. The 
drug was easily taken and no local gastrointestinal disturbances noted. As is the 
case with other thiazide drugs hypochloremic alkalosis was the most frequent electrolyte 
disturbance. This was easily corrected by the administration of chloride replacement 
therapy. 
DISCUSSION 
Polythiazide was felt to be a good oral diuretic agent particularly effective by 
single daily dose administration; effective at least over a twenty-four hour period and 
probably longer. This seems to be its chief clinical advantage. It probably has no 
appreciable less potassium wastage than some of the other thiazide agents. It was 
well tolerated and gave very effective edema weight loss. No serious side effects 
were noted. One case of allergic sensitivity (maculopapular rash) occurred without 
serious sequellae. In one resistant case of congestive failure a surprising degree of 
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diuretic activity occurred after failure of parenteral mercurials although a second 
case of refractory heart failure did not respond. 
In clinical use of this material electrolyte depletion syndromes appear no less 
likely to occur and should be closely watched for their signs of development, partic-
ularly in the patient with advanced cardiac with hepatic cirrhosis and renal failure. 
SUMMARY 
A new benzothiadiazine derivative polythiazide-2-methyl-3-(2,2,2-trifluoroethyhhi-
omethyl)-6-chloro-7-sulfamyl 3-4 dihydro-l,2,4-benzothiadiazine 1,1 dioxide, was given 
to 14 patients with varying degrees of congestive heart failure. Results indicate it 
to be an excellent oral diuretic of prolonged action. Rash allergic sensitivity may 
occur as with other benzothiadiozine analogues. 
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